GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (OTCPK:GENSF) » Definitions » EV-to-EBIT

Genus (GENSF) EV-to-EBIT : 25.42 (As of May. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Genus EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Genus's Enterprise Value is $1,860.4 Mil. Genus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $73.2 Mil. Therefore, Genus's EV-to-EBIT for today is 25.42.

The historical rank and industry rank for Genus's EV-to-EBIT or its related term are showing as below:

GENSF' s EV-to-EBIT Range Over the Past 10 Years
Min: 14.57   Med: 32.9   Max: 171.46
Current: 25.62

During the past 13 years, the highest EV-to-EBIT of Genus was 171.46. The lowest was 14.57. And the median was 32.90.

GENSF's EV-to-EBIT is ranked worse than
73.24% of 426 companies
in the Biotechnology industry
Industry Median: 9.545 vs GENSF: 25.62

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Genus's Enterprise Value for the quarter that ended in Dec. 2023 was $2,192.8 Mil. Genus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $73.2 Mil. Genus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.34%.


Genus EV-to-EBIT Historical Data

The historical data trend for Genus's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus EV-to-EBIT Chart

Genus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 127.21 47.00 55.90 33.90 30.24

Genus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 33.90 - 30.24 -

Competitive Comparison of Genus's EV-to-EBIT

For the Biotechnology subindustry, Genus's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genus's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Genus's EV-to-EBIT falls into.



Genus EV-to-EBIT Calculation

Genus's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1860.439/73.185
=25.42

Genus's current Enterprise Value is $1,860.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $73.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genus  (OTCPK:GENSF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Genus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=73.185/2192.7735225
=3.34 %

Genus's Enterprise Value for the quarter that ended in Dec. 2023 was $2,192.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $73.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genus EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Genus's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Genus (GENSF) Business Description

Traded in Other Exchanges
Address
Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.